Physician profile
Weijia Wang
NPI 1790124360
$19,288.29
in general payments reported to CMS, 2019-2025
12 companies · $1,803 in 2025
The $1,803 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $183 · 2021: $1,356 · 2022: $6,520 · 2023: $6,491 · 2024: $2,661 · 2025: $1,803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,324 · Food and Beverage: $2,502 · Education: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,324.30 |
| Food and Beverage | $2,501.67 |
| Education | $128.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,567.10 | 2022-2025 | Aveir, Ensite Precision, Cardiomems |
| Medical Device Business Services, INC. | $4,050.16 | 2022-2023 | Carto 3 |
| Medtronic, INC. | $3,404.63 | 2021-2025 | Micra, Evera Mri Xt Dr Surescan, Pulseselect |
| Boston Scientific Corporation | $2,285.42 | 2019-2023 | Watchman Flx, Watchman Access System |
| Philips North America LLC | $1,626.47 | 2022-2023 | |
| Biotronik INC. | $1,366.10 | 2021-2022 | |
| Biosense Webster, INC. | $1,199.77 | 2021-2023 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $186.95 | 2020-2024 | Lifevest |
| Abiomed | $185.24 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $156.79 | 2021 | |
| Amgen INC. | $150.00 | 2025 | Repatha, Repatha |
| Zoll Respicardia, INC. | $109.66 | 2023-2024 | Remede System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Weijia Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.